Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Gastroenterol Hepatol ; 30(7): 391-4, 2007.
Artigo em Espanhol | MEDLINE | ID: mdl-17692196

RESUMO

Undifferentiated (embryonal) sarcoma (UES) of the liver is a primary malignant tumor, rarely diagnosed in adults. Because of the absence of specific symptoms, rapid tumor growth, and normality of the common tumor markers, this neoplasm has a poor prognosis. Histologically, UES of the liver is characterized by anaplastic cells within myxoid matrix. Histological, immunohistochemical and chromosomic alterations are similar in UES and in mesenchymal hamartoma, suggesting a relation between these entities. The mainstay of treatment is surgery, while adjuvant treatment could increase survival.


Assuntos
Anemia/etiologia , Neoplasias Hepáticas/complicações , Sarcoma/complicações , Anemia Hipocrômica/etiologia , Humanos , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Sarcoma/patologia
2.
Cir Cir ; 81(2): 169-75, 2013.
Artigo em Espanhol | MEDLINE | ID: mdl-23522321

RESUMO

INTRODUCTION: In 2008, colorectal cancer represented the third most commonly diagnosed tumor in Spain, and the second tumor with more deaths. Despite the new potential biomarkers in colorectal cancer, there are many challenges that need to be overcome, resulting in a need for the standardization of its determinations. DISCUSSION: The continuous advance in tumor disease knowledge makes this review a summary of the current accepted, recommended and studied tumor markers for the diagnosis and monitoring of colorectal cancer, such as fecal markers, tissue markers and serological markers, and various prognostic markers on which there are different lines of treatment in colorectal cancer. CONCLUSIONS: Oncological guidelines recommend only a minority of tumor markers for routine use, such as the study of fecal occult blood, CEA determination in the postoperative followup, microsatellite instability to identify people susceptible to hereditary nonpolyposis colorectal cáncer, and mutation of APC in the diagnosis of familial adenomatous polyposis.


Assuntos
Adenocarcinoma/química , Biomarcadores Tumorais/análise , Neoplasias Colorretais/química , Adenocarcinoma/sangue , Proteínas Angiogênicas/sangue , Antígeno CA-19-9/análise , Antígeno Carcinoembrionário/análise , Cromossomos Humanos Par 18/genética , Neoplasias Colorretais/sangue , DNA de Neoplasias/análise , Fezes/química , Genes Neoplásicos , Humanos , Perda de Heterozigosidade , MicroRNAs/análise , Instabilidade de Microssatélites , Sangue Oculto , Guias de Prática Clínica como Assunto , Prevalência , RNA Neoplásico/análise , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA